Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2018, Article ID 4851949, 10 pages
https://doi.org/10.1155/2018/4851949
Research Article

Stemness-Attenuating miR-503-3p as a Paracrine Factor to Regulate Growth of Cancer Stem Cells

1Prostemics Research Institute, Seongdong-gu, Seoul 135-010, Republic of Korea
2Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seongbuk-Gu, Seoul 136-791, Republic of Korea

Correspondence should be addressed to Mihue Jang; rk.er.tsik@euhim

Received 29 September 2017; Revised 3 January 2018; Accepted 24 January 2018; Published 4 April 2018

Academic Editor: Pratima Basak

Copyright © 2018 Minkoo Seo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Antonyak and R. A. Cerione, “Emerging picture of the distinct traits and functions of microvesicles and exosomes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 12, pp. 3589-3590, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Théry, L. Zitvogel, and S. Amigorena, “Exosomes: composition, biogenesis and function,” Nature Reviews Immunology, vol. 2, no. 8, pp. 569–579, 2002. View at Publisher · View at Google Scholar
  3. S. EL Andaloussi, I. Mäger, X. O. Breakefield, and M. J. A. Wood, “Extracellular vesicles: biology and emerging therapeutic opportunities,” Nature Reviews Drug Discovery, vol. 12, no. 5, pp. 347–357, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Johnstone, A. Mathew, A. B. Mason, and K. Teng, “Exosome formation during maturation of mammalian and avian reticulocytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins,” Journal of Cellular Physiology, vol. 147, no. 1, pp. 27–36, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Stremersch, R. E. Vandenbroucke, E. Van Wonterghem, A. Hendrix, S. C. De Smedt, and K. Raemdonck, “Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs,” Journal of Controlled Release, vol. 232, pp. 51–61, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Vader, E. A. Mol, G. Pasterkamp, and R. M. Schiffelers, “Extracellular vesicles for drug delivery,” Advanced Drug Delivery Reviews, vol. 106, no. Part A, pp. 148–156, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. I. K. Kim, S. H. Kim, S. M. Choi, B. S. Youn, and H. S. Kim, “Extracellular vesicles as drug delivery vehicles for rheumatoid arthritis,” Current Stem Cell Research & Therapy, vol. 11, no. 4, pp. 329–342, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Zhang, H. Tu, Y. Yang, L. Fang, Q. Wu, and J. Li, “Mesenchymal stem cell-derived extracellular vesicles: roles in tumor growth, progression, and drug resistance,” Stem Cells International, vol. 2017, Article ID 1758139, 12 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Yu, Y. Wei, Y. Xu, Y. Zhang, J. Li, and J. Zhang, “Extracellular vesicles in breast cancer drug resistance and their clinical application,” Tumour Biology, vol. 37, no. 3, pp. 2849–2861, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. P. D. Robbins and A. E. Morelli, “Regulation of immune responses by extracellular vesicles,” Nature Reviews Immunology, vol. 14, no. 3, pp. 195–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. D’Souza-Schorey and D. Di Vizio, “Biology and proteomics of extracellular vesicles: harnessing their clinical potential,” Expert Review of Proteomics, vol. 11, no. 3, pp. 251–253, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. van Dommelen, P. Vader, S. Lakhal et al., “Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery,” Journal of Controlled Release, vol. 161, no. 2, pp. 635–644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Wu, Z. Qu, Z. W. Fei, J. H. Wu, and C. P. Jiang, “Role of stem cell-derived exosomes in cancer,” Oncology Letters, vol. 13, no. 5, pp. 2855–2866, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. K. C. Vallabhaneni, P. Penfornis, S. Dhule et al., “Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites,” Oncotarget, vol. 6, no. 7, pp. 4953–4967, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Zhu, L. Huang, Y. Li et al., “Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo,” Cancer Letters, vol. 315, no. 1, pp. 28–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Kahlert and R. Kalluri, “Exosomes in tumor microenvironment influence cancer progression and metastasis,” Journal of Molecular Medicine, vol. 91, no. 4, pp. 431–437, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Wang, Y. Zheng, and M. Zhao, “Exosome-based cancer therapy: implication for targeting cancer stem cells,” Frontiers in Pharmacology, vol. 7, p. 533, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Del Fattore, R. Luciano, R. Saracino et al., “Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells,” Expert Opinion on Biological Therapy, vol. 15, no. 4, pp. 495–504, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Bruno, F. Collino, M. C. Deregibus, C. Grange, C. Tetta, and G. Camussi, “Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth,” Stem Cells and Development, vol. 22, no. 5, pp. 758–771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Katakowski, B. Buller, X. Zheng et al., “Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth,” Cancer Letters, vol. 335, no. 1, pp. 201–204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Katakowski, X. Zheng, F. Jiang, T. Rogers, A. Szalad, and M. Chopp, “MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma,” Cancer Investigation, vol. 28, no. 10, pp. 1024–1030, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Wu, G. Q. Ju, T. Du, Y. J. Zhu, and G. H. Liu, “Microvesicles derived from human umbilical cord Wharton’s jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo,” PLoS One, vol. 8, no. 4, article e61366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. G. Doench and P. A. Sharp, “Specificity of microRNA target selection in translational repression,” Genes & Development, vol. 18, no. 5, pp. 504–511, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Zhang, S. Y. Zhou, H. Z. Yan et al., “miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1,” Scientific Reports, vol. 6, no. 1, article 19995, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Guessous, Y. Zhang, A. Kofman et al., “microRNA-34a is tumor suppressive in brain tumors and glioma stem cells,” Cell Cycle, vol. 9, no. 6, pp. 1031–1036, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. J. Choi, C. P. Lin, J. J. Ho et al., “miR-34 miRNAs provide a barrier for somatic cell reprogramming,” Nature Cell Biology, vol. 13, no. 11, pp. 1353–1360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Shang, Y. Guo, Y. Hong, Y. H. Liu, and Y. X. Xue, “MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG,” Molecular Biology Reports, vol. 42, no. 3, pp. 721–727, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Y. Kang, “MicroRNA-21 regulates stemness in cancer cells,” Stem Cell Research & Therapy, vol. 4, no. 5, p. 110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Osaki, F. Okada, and T. Ochiya, “miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence,” Therapeutic Delivery, vol. 6, no. 3, pp. 323–337, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. B. S. Park, W. S. Kim, J. S. Choi et al., “Hair growth stimulated by conditioned medium of adipose-derived stem cells is enhanced by hypoxia: evidence of increased growth factor secretion,” Biomedical Research, vol. 31, no. 1, pp. 27–34, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Viale, F. De Franco, A. Orleth et al., “Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells,” Nature, vol. 457, no. 7225, pp. 51–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Bruno, F. Collino, A. Iavello, and G. Camussi, “Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth,” Frontiers in Immunology, vol. 5, p. 382, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. A. A. Svoronos, D. M. Engelman, and F. J. Slack, “OncomiR or tumor suppressor? The duplicity of MicroRNAs in cancer,” Cancer Research, vol. 76, no. 13, pp. 3666–3670, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. D. L. Holliday and V. Speirs, “Choosing the right cell line for breast cancer research,” Breast Cancer Research, vol. 13, no. 4, p. 215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Yan, X. Zuo, and D. Wei, “Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target,” Stem Cells Translational Medicine, vol. 4, no. 9, pp. 1033–1043, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. M. L. Wang, S. H. Chiou, and C. W. Wu, “Targeting cancer stem cells: emerging role of Nanog transcription factor,” OncoTargets and Therapy, vol. 6, pp. 1207–1220, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Gong, Y. Wang, J. Zhang, and Z. Wang, “Differential hepatic stem cell proliferation and differentiation after partial hepatectomy in rats,” Molecular Medicine Reports, vol. 8, no. 4, pp. 1005–1010, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Lapidot, C. Sirard, J. Vormoor et al., “A cell initiating human acute myeloid leukaemia after transplantation into SCID mice,” Nature, vol. 367, no. 6464, pp. 645–648, 1994. View at Publisher · View at Google Scholar
  40. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, “Prospective identification of tumorigenic breast cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983–3988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. C. A. O’Brien, A. Pollett, S. Gallinger, and J. E. Dick, “A human colon cancer cell capable of initiating tumour growth in immunodeficient mice,” Nature, vol. 445, no. 7123, pp. 106–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Fang, T. K. Nguyen, K. Leishear et al., “A tumorigenic subpopulation with stem cell properties in melanomas,” Cancer Research, vol. 65, no. 20, pp. 9328–9337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. J. E. Visvader and G. J. Lindeman, “Cancer stem cells in solid tumours: accumulating evidence and unresolved questions,” Nature Reviews Cancer, vol. 8, no. 10, pp. 755–768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, “Stem cells, cancer, and cancer stem cells,” Nature, vol. 414, no. 6859, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. Hu and L. Fu, “Targeting cancer stem cells: a new therapy to cure cancer patients,” American Journal of Cancer Research, vol. 2, no. 3, pp. 340–356, 2012. View at Google Scholar
  46. Y. Sun, L. Li, S. Xing et al., “miR-503-3p induces apoptosis of lung cancer cells by regulating p21 and CDK4 expression,” Cancer Biomark, vol. 20, no. 4, pp. 597–608, 2017. View at Publisher · View at Google Scholar · View at Scopus